N-Methyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

1,2-Dimethyl-3-propyl-1H-imidazol-3-ium iodide, 95.0%, 5g

1-(3-CHLOROQUINOLIN-7-YL)ETHANONE, 95.0%, 250mg

Trihexyl(tetradecyl)phosphonium Bis((trifluoromethyl)sulfonyl)amide25g

Methyl 2-(3-bromophenyl)-2-cyanoacetate, 98%, 10g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile, 97%, 100mg

4-(Difluoromethoxy)benzylamine, 97.0%, 5g

(3,3-difluoropiperidin-4-yl)methanol hydrochloride, 95.0%, 1g

H-Trp-NH2�HCl, 95%, 5g

4-(4-Chloro-1,2,5-thiadiazol-3-yl)morpholine, 97.0%, 10g

Ethyl 2-Amino-4-methylthiophene-3-carboxylate>98.0%(GC)(T)5g

4-Amino-3-chloro-5-iodobenzonitrile, 95.0%, 25g

GC capillary column ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)